74 related articles for article (PubMed ID: 2125326)
1. [Hyperlipoproteinemia: classification and current problems].
Murase T
Nihon Rinsho; 1990 Nov; 48(11):2519-25. PubMed ID: 2125326
[No Abstract] [Full Text] [Related]
2. [Recent trend in the research of hyperlipidemia in Japan. Treatment of refractory hyperlipidemia].
Saito Y; Yoshida S
Nihon Naika Gakkai Zasshi; 1989 Oct; 78(10):1416-9. PubMed ID: 2513364
[No Abstract] [Full Text] [Related]
3. Effects of CS-514, a new inhibitor of HMG CoA reductase, on plasma lipids, lipoproteins and apoproteins in patients with primary hypercholesterolemia.
Kazumi T; Yoshino G; Kasama T; Iwatani I; Iwai M; Morita S; Baba S
Horm Metab Res; 1986 Sep; 18(9):654-5. PubMed ID: 3096862
[No Abstract] [Full Text] [Related]
4. Probucol versus eptastatin in hypercholesterolaemic diabetics.
Yoshino G; Kazumi T; Uenoyama R; Inui A; Kasama T; Iwatani I; Iwai M; Yokono K; Otsuki M; Baba S
Lancet; 1986 Sep; 2(8509):740-1. PubMed ID: 2876200
[No Abstract] [Full Text] [Related]
5. Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia.
Franceschini G; Sirtori M; Vaccarino V; Gianfranceschi G; Chiesa G; Sirtori CR
J Lab Clin Med; 1989 Sep; 114(3):250-9. PubMed ID: 2504855
[TBL] [Abstract][Full Text] [Related]
6. Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis.
Circulation; 1984 May; 69(5):1067A-1090A. PubMed ID: 6368042
[No Abstract] [Full Text] [Related]
7. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
Illingworth DR; Bacon S
Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189
[TBL] [Abstract][Full Text] [Related]
8. [HDL-2000: A consensus. HDL--a neglected lipoprotein].
Sinzinger H; Hoppichler F; Kritz H; Laimer H; Schmid P; Silberbauer K; Toplak H;
Wien Klin Wochenschr; 2001 Mar; 113(5-6):212-4. PubMed ID: 11293953
[No Abstract] [Full Text] [Related]
9. Pathogenesis and management of lipoprotein disorders.
Schaefer EJ; Levy RI
N Engl J Med; 1985 May; 312(20):1300-10. PubMed ID: 3887163
[No Abstract] [Full Text] [Related]
10. [Classification and etiology of hyperlipoproteinemia].
Kita T
Nihon Naika Gakkai Zasshi; 1991 Jul; 80(7):1141-7. PubMed ID: 1919230
[No Abstract] [Full Text] [Related]
11. [Comparison of the effectiveness of the HMG-CoA-reductase inhibitors pravastatin versus colestyramine in hypercholesteremia].
Schwartzkopff W; Bimmermann A; Schleicher J
Arzneimittelforschung; 1990 Dec; 40(12):1322-7. PubMed ID: 2128866
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of pravastatin and bezafibrate in primary hypercholesterolemia].
Arntz HR; Bönner G; Kikis D; Kirch W; Klör HU; Lederle RM; Overlack A; Steinmetz A; Stumpe KO
Dtsch Med Wochenschr; 1991 Jan; 116(1):7-12. PubMed ID: 1898717
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the efficacy and safety of pravastatin in primary hypercholesterolemia].
Craveri A; Citella C; Lanfredini M; Colombo L; Bruschi R
Boll Chim Farm; 1990 Jun; 129(6):10S-15S. PubMed ID: 2127364
[TBL] [Abstract][Full Text] [Related]
14. [Hypertriglyceridemias].
Delgado M; Torres MA; Bellod P; Rubio MJ; Azpeitia JG; Nuño J; de Oya M
Rev Clin Esp; 1985 Oct; 177(5):203-8. PubMed ID: 3909257
[No Abstract] [Full Text] [Related]
15. [Hyperlipoproteinemia--problems of diagnosis and treatment. Report of the Working Group of the Polish Cardiology Society].
Michajlik A; Ciświcka-Sznajderman M; Sznajd J; Szostak W
Kardiol Pol; 1982; 25(12):1061-8. PubMed ID: 7169735
[No Abstract] [Full Text] [Related]
16. [Primary hyperlipoproteinemias. Clinical, biological and physiopathological aspects].
Bakir R; Chanu B; Rouffy J
Pathol Biol (Paris); 1983 Apr; 31(4):248-58. PubMed ID: 6346238
[TBL] [Abstract][Full Text] [Related]
17. Treating hyperlipidemia, Part III: Drug therapy.
Smith DA; Karmally W; Brown WV
Geriatrics; 1987 Aug; 42(8):55-9, 62. PubMed ID: 3110017
[TBL] [Abstract][Full Text] [Related]
18. [Improved diagnosis of lipoproteins with vasoprotective and vasoaggresive properties].
Mertz DP
Lebensversicher Med; 1979 Nov; 31(6):151-5. PubMed ID: 44336
[No Abstract] [Full Text] [Related]
19. [Pravastatin vs. probucol in the treatment of hypercholesterolemia. A double-blind study].
Sienra-Pérez JC; Lerman-Garber I; Ahumada-Ayala M; Castañón-Romo C; Cardoso-Saldaña G; Laguna-Castellanos M; Posadas-Romero C
Arch Inst Cardiol Mex; 1991; 61(4):365-73. PubMed ID: 1953212
[TBL] [Abstract][Full Text] [Related]
20. Pravastatin vs gemfibrozil in the treatment of primary hypercholesterolemia. The Italian Multicenter Pravastatin Study I.
Crepaldi G; Baggio G; Arca M; Avellone G; Avogaro P; Bittolo Bon G; Bompiani GD; Capurso A; Cattin L; D'Alŏ G
Arch Intern Med; 1991 Jan; 151(1):146-52. PubMed ID: 1898694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
